Solvonis Therapeutics plc (LON:SVNS)

London flag London · Delayed Price · Currency is GBP · Price in GBX
0.3600
0.00 (0.00%)
At close: Jul 15, 2025, 4:30 PM BST
20.00%
Market Cap 21.27M
Revenue (ttm) n/a
Net Income (ttm) -1.59M
Shares Out 5.91B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 102,784,103
Average Volume 120,790,796
Open 0.3555
Previous Close 0.3600
Day's Range 0.3400 - 0.3700
52-Week Range 0.1095 - 0.3800
Beta 1.67
RSI 79.46
Earnings Date Sep 12, 2025

About Solvonis Therapeutics

Solvonis Therapeutics plc, together with its subsidiaries, researches and develops polymer modification technologies and techniques in the United Kingdom, Slovenia, and Europe. The company offers GRAFTABOND, a line of graft/block copolymers for combining various polymers with fiberglass, carbon fiber, mineral, natural fillers, and mixed polymer waste; GRAFTALEN, a line of reactive solid super-concentrates for polyolefin rheology modification, e-modulus enhancers, PET/PBT chain extenders, and AOX masterbatch; and GRAFTAPOR, a line of porous poly... [Read more]

Sector Industrials
Founded 2017
Employees 3
Stock Exchange London Stock Exchange
Ticker Symbol SVNS
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.